These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21645413)

  • 1. Proteomics research on muscle-invasive bladder transitional cell carcinoma.
    Niu HT; Dong Z; Jiang G; Xu T; Liu YQ; Cao YW; Zhao J; Wang XS
    Cancer Cell Int; 2011 Jun; 11(1):17. PubMed ID: 21645413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer stroma proteome expression profile of superficial bladder transitional cell carcinoma and biomarker discovery.
    Niu HT; Yang CM; Jiang G; Xu T; Cao YW; Zhao J; Wang XS
    J Cancer Res Clin Oncol; 2011 Aug; 137(8):1273-82. PubMed ID: 21706132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stromal proteome expression profile and muscle-invasive bladder cancer research.
    Niu H; Jiang H; Cheng B; Li X; Dong Q; Shao L; Liu S; Wang X
    Cancer Cell Int; 2012 Aug; 12(1):39. PubMed ID: 22920603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in shotgun protein expression profile between superficial bladder transitional cell carcinoma and normal urothelium.
    Niu HT; Zhang YB; Jiang HP; Cheng B; Sun G; Wang Y; E YJ; Pang de Q; Chang JW
    Urol Oncol; 2009; 27(4):400-6. PubMed ID: 18818109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shotgun proteome expression profile of microdissected superficial transitional cell carcinoma and biomarker discovery from urine.
    Niu HT; Li SJ; Xu T; Yu QC; Chang JW; Sun G
    Mol Med Rep; 2009; 2(5):719-23. PubMed ID: 21475891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parallel proteomic analysis in muscle-invasive bladder transitional cell carcinoma and cancer-related stroma.
    Niu HT; Qi XJ; Liu YQ; Cao YW; Dong Q; Wang XS
    Genet Mol Res; 2013 Feb; 12(4):4251-63. PubMed ID: 23479173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarker research and some deduction in superficial bladder cancer cells combined with corresponding stroma.
    Niu HT; Yang CM; Chen B; Dong Q
    Cancer Biomark; 2011-2012; 10(2):109-16. PubMed ID: 22430138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Far from resolved: stromal cell-based iTRAQ research of muscle-invasive bladder cancer regarding heterogeneity.
    Liu PF; Wang YH; Cao YW; Jiang HP; Yang XC; Wang XS; Niu HT
    Oncol Rep; 2014 Oct; 32(4):1489-96. PubMed ID: 25050759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity research in muscle-invasive bladder cancer based on differential protein expression analysis.
    Liu PF; Cao YW; Jiang HP; Wang YH; Yang XC; Wang XS; Niu HT
    Med Oncol; 2014 Sep; 31(9):21. PubMed ID: 25085780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Tissue Proteomics of Microdissected Specimens Reveals Novel Candidate Biomarkers of Bladder Cancer.
    Chen CL; Chung T; Wu CC; Ng KF; Yu JS; Tsai CH; Chang YS; Liang Y; Tsui KH; Chen YT
    Mol Cell Proteomics; 2015 Sep; 14(9):2466-78. PubMed ID: 26081836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential proteomic analysis of nuclear matrix in muscle-invasive bladder cancer: potential to improve diagnosis and prognosis.
    Barboro P; Rubagotti A; Orecchia P; Spina B; Truini M; Repaci E; Carmignani G; Romagnoli A; Introini C; Boccardo F; Carnemolla B; Balbi C
    Cell Oncol; 2008; 30(1):13-26. PubMed ID: 18219107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SH3BGRL3 Protein as a Potential Prognostic Biomarker for Urothelial Carcinoma: A Novel Binding Partner of Epidermal Growth Factor Receptor.
    Chiang CY; Pan CC; Chang HY; Lai MD; Tzai TS; Tsai YS; Ling P; Liu HS; Lee BF; Cheng HL; Ho CL; Chen SH; Chow NH
    Clin Cancer Res; 2015 Dec; 21(24):5601-11. PubMed ID: 26286913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of pathway biomarkers from coupled proteomics and systems biology methods.
    Zhang F; Chen JY
    BMC Genomics; 2010 Nov; 11 Suppl 2(Suppl 2):S12. PubMed ID: 21047379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In situ proteomic analysis of human breast cancer epithelial cells using laser capture microdissection: annotation by protein set enrichment analysis and gene ontology.
    Cha S; Imielinski MB; Rejtar T; Richardson EA; Thakur D; Sgroi DC; Karger BL
    Mol Cell Proteomics; 2010 Nov; 9(11):2529-44. PubMed ID: 20739354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic Profiling of Ectosomes Derived from Paired Urothelial Bladder Cancer and Normal Cells Reveals the Presence of Biologically-Relevant Molecules.
    Surman M; Kędracka-Krok S; Jankowska U; Drożdż A; Stępień E; Przybyło M
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34202855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated Fourier Transform Infrared Imaging and Proteomics for Identification of a Candidate Histochemical Biomarker in Bladder Cancer.
    Witzke KE; Großerueschkamp F; Jütte H; Horn M; Roghmann F; von Landenberg N; Bracht T; Kallenbach-Thieltges A; Käfferlein H; Brüning T; Schork K; Eisenacher M; Marcus K; Noldus J; Tannapfel A; Sitek B; Gerwert K
    Am J Pathol; 2019 Mar; 189(3):619-631. PubMed ID: 30770125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative proteomics analysis in different stages of urothelial bladder cancer for identification of potential biomarkers: highlighted role for antioxidant activity.
    Tabaei S; Haghshenas MR; Ariafar A; Gilany K; Stensballe A; Farjadian S; Ghaderi A
    Clin Proteomics; 2023 Jul; 20(1):28. PubMed ID: 37501157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of Label-Free Proteomics for Quantitative Analysis of Urothelial Carcinoma and Cystitis Tissue.
    Witzke KE; Großerueschkamp F; Gerwert K; Sitek B
    Methods Mol Biol; 2021; 2228():283-292. PubMed ID: 33950498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the expression protein profiles of lung squamous carcinoma cell using shot-gun proteomics strategy.
    Nan Y; Yang S; Tian Y; Zhang W; Zhou B; Bu L; Huo S
    Med Oncol; 2009; 26(2):215-21. PubMed ID: 18988000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative Proteomic Analysis Identifies AHNAK (Neuroblast Differentiation-associated Protein AHNAK) as a Novel Candidate Biomarker for Bladder Urothelial Carcinoma Diagnosis by Liquid-based Cytology.
    Lee H; Kim K; Woo J; Park J; Kim H; Lee KE; Kim H; Kim Y; Moon KC; Kim JY; Park IA; Shim BB; Moon JH; Han D; Ryu HS
    Mol Cell Proteomics; 2018 Sep; 17(9):1788-1802. PubMed ID: 29950347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.